Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders (Q65378022)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders |
clinical trial |
Statements
NRSily (English)
0 references
Multicenter Study To Evaluate The Efficacy Of Silymarin In Addition To Combination-Therapy With Pegylated Interferon Alfa 2a (Peg-Ifn Alfa 2a) And Ribavirin In Patients With Chronic Hepatitis C (English)
0 references
October 2007
0 references
February 2011
0 references
70
0 references
19 year
0 references
70 year
0 references